Patterson Companies | PDCO - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1.06B 35.07M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Cardinal Health USD 3.94B 1.16B 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
Cooper Companies USD 110.6M 14.3M 2025-09
CVS Health USD 9.54B 1.09B 2026-03
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
eHealth USD 63.09M 2.83M 2025-09
Henry Schein USD 138M 18M 2026-03
Idexx Laboratories USD 200.53M 20.46M 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
McKesson USD 3.98B 1.02B 2026-03
Mettler Toledo International USD 66.89M 2.18M 2025-12
Owens Minor USD 336.88M 54.89M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 462M 125.83M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03
Zoetis USD 1.94B 369M 2026-03